Vancomycin penetration into heart tissues (valves, myocardium, auricles, and pericardium) and mediastinal tissues (fat and sternal bone) was evaluated after two regimens of vancomycin administration. Ten patients were given 15 mg of vancomycin per kg of body weight before anesthesia. Ten other patients received the same dose and then a second 7.5-mg/kg dose at the time of initiation of cardiopulmonary bypass. Similar and satisfactory vancomycin tissue penetrations were observed in both groups. However, for some patients in the two groups, vancomycin levels in tissue were less than the MICs for potential pathogens (Staphylococcus aureus and Staphylococcus epidermidis).
Vancomycin penetration into heart tissues (valves, myocardium, auricles, and pericardium) and mediastinal tissues (fat and sternal bone) was evaluated after two regimens of vancomycin administration. Ten patients were given 15 mg of vancomycin per kg of body weight before anesthesia. Ten other patients received the same dose and then a second 7.5-mg/kg dose at the time of initiation of cardiopulmonary bypass. Similar and satisfactory vancomycin tissue penetrations were observed in both groups. However, for some patients in the two groups, vancomycin levels in tissue were less than the MICs for potential pathogens (Staphylococcus aureus and Staphylococcus epidermidis).
Cardiac surgery is a clean surgery but requires antibiotic prophylaxis to prevent serious postoperative infections of the cardiac valves or the mediastinal tissues (1) . Antibiotic prophylaxis is used to protect against pathogens most likely to contaminate the surgical wound, that is, methicillin-resistant or susceptible staphylococci. Cephalosporins (cefazolin, cefamandole) are widely used for that purpose, but vancomycin is an alternative for prophylaxis in allergic patients or when a risk of postoperative infections because of methicillin-resistant staphylococci exists (6, 8) . Vancomycin is characterized by a slow killing rate of bacteria, and this is particularly true for low levels of the drug (half the MIC) (16) . Given this time dependency for bacterial killing, exposure of bacteria to antibiotic concentrations greater than the MIC for long periods of time seems desirable. For prophylaxis for postoperative infections, such adequate antibiotic concentrations should probably be achieved in all potential sites of infection (2, 13) .
The present study was designed to determine whether two different dose regimens could result in the achievement and maintenance of adequate concentrations in sternal bone, mediastinal fat, and heart tissues. Levels in tissue greater than or equal to the MIC for 90% of methicillin-susceptible or resistant Staphylococcus aureus (1 ,ug/ml) and coagulase-negative staphylococci (2 ,ug/ml) tested (19) were considered adequate.
Subject and study design. The study received the approval of the Ethics Committee of our institution (Hopital Nord), and all patients gave informed consent. The study was prospective and randomized and was designed to compare the penetration of vancomycin after either a single (group 1) or two (group 2) intraoperative intravenous doses in patients undergoing mitral or aortic valve replacement. Twenty patients, divided into two groups of 10 patients each, were included in the study. Criteria for inclusion were as follows: 18 years of age or older, absence of prior history of hepatic or renal disease, elective surgery, and no clinical or laboratory signs of infection. Antibiotic administration. Group muscle], a fragment of the resected valve, and a fragment of the right auricle); and at the time of thorax closure (pericardium, sternal bone, and thoracic wall fat). Additional blood samples were obtained at the following periods: before vancomycin infusion (control), 10 min after the end of vancomycin infusion (peak level), before the initiation of CPB, 10 min after the end of the second vancomycin infusion (group 2; second peak level), at the end of aortic cross-clamping, at the end of CPB, and on hour 8 (prior to the first postoperative vancomycin infusion).
Vancomycin assay. Vancomycin was assayed in plasma and tissues by a fluorescence polarization immunoassay (TDX; Abbott Laboratories). Tissue specimens were reduced to a fine powder with a SPEX 6700 crusher (SPEX Industries, Edison, N.J.). The frozen tissue fragments were pulverized under liquid nitrogen for 1 min. The resulting powder was taken up in phosphate buffer, and the mixture was shaken for 24 h at 4°C. The homogenate was centrifuged and filtered. Vancomycin ,ug/ml, 3.9 and 5.2%, respectively, at 25 ,ug/ml, and 2.3 and 4.6%, respectively, at 75 ,ug/ml.
CPB. Anticoagulation was induced with heparin (300 IU/kg) and was monitored by the activated clotting time (over 400 s during CPB). The CPB pump (SARNS 9000; 3M Sante Laboratory, Malakoff, France) was primed with 500 ml of lactated Ringer solution, 500 ml of 14% bicarbonate, and 500 ml of dextran (molecular weight, 60,000 The two groups were matched for the studied parameters. In group 1 (10 patients), the mean age was 48 ± 10 years, the duration of CPB was 63 ± 9 min, and the duration of aortic cross-clamping was 37 ± 19 min. In group 2 (10 patients), the mean age was 43 ± 20 years, the duration of CPB was 76 22 min, and the duration of aortic cross-clamping was 50 14 min.
Vancomycin levels in plasma. Figure 1 shows the evolution of vancomycin levels in the plasma of both groups at different periods. Plasma vancomycin levels were strictly identical in the two groups until T3 (initiation of CPB). Peak levels (Ti) were 34.2 ± 12.1 mg/liter in group 1 and 37.5 ± 10.5 mg/liter in group 2. At T3 (132 ± 17 min), patients in group 2 received a second infusion of vancomycin (7.5 mg/kg). A second peak of vancomycin (48 ± 12 mg/l) was observed in group 2 at T4. From T4 to T7 (closure of the thorax), plasma vancomycin levels were significantly higher in group 2 patients than in group 1 patients (P < 0.05). At hour 8 after the first infusion, (T8) both groups had similar plasma vancomycin levels (group 1, 6 ± 4.2 mg/liter; group 2, 9.8 ± 5.1 mg/liter). At that time, both groups received a second (group 1) or a third (group 2) vancomycin injection of 10 mg/kg and then similar injections at hours 16 Vancomycin penetration in mediastinal and cardiac tissues. Figure 2 shows the vancomycin concentrations in various tissues during surgery in both groups. During the beginning stages of surgery, before CPB, a higher level of drug penetration was observed in the pericardium than in thoracic wall fat and sternal bone. During the second period (CBP), similar vancomycin concentrations were achieved in the myocardium and auricle and concentrations in the resected valves were slightly lower. During the third period (end of surgery), the pattern of vancomycin penetration in tissues (pericardium, sternal bone, and thoracic wall fat) was similar to that observed during the first period. When the two regimens of vancomycin administration were compared, no significant difference between concentrations in tissue was observed. During the third period, concentrations in sternal bone and thoracic wall fat were higher in group 2 (7.1 ± 6.6. and 5.0 ±+ 4.6 p.g/g, respectively) than in group 1 (4.6 ± 4.1 and 4.6 ± 3.0 p.g/g, respectively), but this difference did not reach the level of significance (Fig. 2) .
In both groups, the ratios of tissue concentrations/MICs for 90% of staphylococci (Staphylococcus aureus, 1 ,ug/g; Staphylococcus epidermidis, 2 ,ug/g) tested (MIC90) were calculated in order to evaluate the potential clinical efficacy of vancomycin concentrations achieved with both regimens of administration. Ratios were between 3 and 20. For S. aureus, the ratios were between 6 and 20, and for S. epidermidis, the ratios were between 3 and 10. When the two regimens of vancomycin administration were compared, no significant difference was observed between the ratios achieved during surgery. When tissues were compared, higher ratios (between 7.5 and 20) were achieved in the myocardium and pericardium (P < 0.05).
The proportion of patients with vancomycin concentrations in tissue that were greater than or equal to the MIC9Os for S.
aureus and S. epidermidis were calculated for both groups during the different periods studied. When the two regimens of vancomycin administration were compared, no significant difference was observed between the two groups (Table 1) . Previous studies have established the basic principles of antibiotic prophylaxis in surgical procedures, and the main points are (i) that the antibiotic must be present in the involved tissues before surgery allows bacterial contamination and (ii) that the drug must attain and maintain concentrations in plasma and tissues high enough to inhibit the growth of contaminating pathogens (9, 17, 18) . The present study confirms the effective penetration of vancomycin into human mediastinal and heart tissues. Concentrations in the heart valves, myocardium, and right auricle were high and in most cases greater than or equal to the MIC90 for usually susceptible pathogens. Furthermore, very satisfactory levels were also achieved in the pericardium, sternal bone, and thoracic wall fat. For instance, in sternal bone, vancomycin concentrations were 30 to 60% of the concentrations in plasma, confirming the results of a previous report (12) . This penetration was greater than the 20 to 30% reported for cefazolin (14) and cefamandole (7 (3, 4) .
In the present study, we compared two regimens of vancomycin administration, and one group of patients (group 2) received a second intraoperative dose of 7.5 mg of vancomycin per kg at the time of initiation of CPB. Many physiological changes occur in patients placed on CBP, and this technique is known to alter drug levels in plasma (8, 15) . At least two factors can explain this result: a rapid increase in the volume of distribution because of the additional volume in the priming pump (11) and drug sequestration within the CPB circuit, which has been demonstrated for fentanyl (8) and nitroglycerin (5) but is only suspected for vancomycin (10) . Whatever the mechanism, plasma vancomycin concentrations decrease when the patient is placed on CPB. To prevent such an effect, one of our groups received a second dose of vancomycin when CPB was started. This resulted in significantly higher plasma vancomycin levels in group 2 up to T7 (end of surgery). Levels in tissue were not different between the two groups during the period of CPB since cardiac tissues were excluded from the general circulation. After aortic unclamping, an increase (although nonsignificant) in plasma vancomycin levels was observed at T6 and T7. This was probably explained by the fact that upon rewarming and increased blood circulation, vancomycin returned to the intravascular volume from peripheral tissues, as well as from tissues which were isolated from the CPB circuit (10) . This increase in plasma vancomycin levels in group 1 patients probably explained why the concentrations in tissue were not different between the two groups at the end of surgery.
Achieving and maintaining sufficient drug concentrations in tissues to avert the risk of postoperative infection are important goals when using antibiotics with a time-dependent efficacies, such as vancomycin. Optimal concentrations should be maintained throughout the surgical procedures. With vancomycin, efficacy is directly related to the time during which its concentration in target tissues exceeds the MIC for the offending organism. Little gain in the rate or extent of killing is obtained by increasing concentrations above that level.
In conclusion, the use of vancomycin at 15 mg/kg before cardiac surgery allowed us to achieve and maintain throughout the operative procedures antibiotic concentrations in tissues greater than the MIC for S. aureus and S. epidermidis in most of the patients who we studied. In some patients, however, this dose regimen did not result in adequate concentrations in tissues. The use of a second intraoperative dose of 7.5 mg of vancomycin per kg at the time of institution of CPB resulted in higher levels in plasma, but penetration into tissue was not significantly improved. With both drug administration regimens that we tested, some patients remained at risk of postoperative infection.
